Elkhorn Partners’s Cardiff Oncology CRDF Stock Holding History

Elkhorn Partners’s Portfolio CRDF Stock Details CRDF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$107K	Buy	34,000 +1,500	+5%	+$4.73K	0.08%	26
2025 Q1	$102K	Buy	32,500 +500	+2%	+$1.57K	0.07%	25
2024 Q4	$139K	Sell	32,000 -13,000	-29%	-$56.5K	0.09%	23
2024 Q3	$120K	Buy	45,000 +4,000	+10%	+$10.7K	0.08%	27
2024 Q2	$91K	Buy	41,000 +2,000	+5%	+$4.44K	0.06%	29
2024 Q1	$208K	Sell	39,000 -26,500	-40%	-$141K	0.15%	21
2023 Q4	$97K	Buy	65,500 +20,500	+46%	+$30.4K	0.07%	29
2023 Q3	$63K	Sell	45,000 -2,000	-4%	-$2.8K	0.04%	38
2023 Q2	$69K	Buy	47,000 +12,000	+34%	+$17.6K	0.04%	37
2023 Q1	$58K	Buy	35,000 +5,592	+19%	+$9.27K	0.04%	33
2022 Q4	$41K	Buy	29,408 +4,108	+16%	+$5.73K	0.03%	33
2022 Q3	$39K	Buy	25,300 +1,500	+6%	+$2.31K	0.03%	34
2022 Q2	$52K	Buy	23,800 +4,800	+25%	+$10.5K	0.03%	34
2022 Q1	$47K	Buy	19,000 +1,700	+10%	+$4.21K	0.03%	35
2021 Q4	$104K	Buy	17,300 +3,800	+28%	+$22.8K	0.06%	27
2021 Q3	$90K	Buy	13,500 +7,500	+125%	+$50K	0.05%	30
2021 Q2	$40K	Buy	6,000 +4,700	+362%	+$31.3K	0.02%	32
2021 Q1	$12K	Buy	1,300 +460	+55%	+$4.25K	0.01%	42
2020 Q4	$15K	Sell	840 -160	-16%	-$2.86K	0.01%	31
2020 Q3	$14K	Sell	1,000 -6,562	-87%	-$91.9K	0.01%	35
2020 Q2	$38K	Sell	7,562 -26,138	-78%	-$131K	0.03%	32
2020 Q1	$34K	Sell	33,700 -3,300	-9%	-$3.33K	0.03%	32
2019 Q4	$46K	Hold	37,000	–	–	0.03%	35
2019 Q3	$56K	Buy	37,000 +17,000	+85%	+$25.7K	0.03%	34
2019 Q2	$50K	Buy	+20,000	New	+$50K	0.03%	33
2019 Q1	–	Sell	-14,861	Closed	-$46K	–	32
2018 Q4	$46K	Hold	14,861	–	–	0.03%	29
2018 Q3	$73K	Hold	14,861	–	–	0.04%	28
2018 Q2	$69K	Buy	14,861 +10,833	+269%	+$50.3K	0.04%	32
2018 Q1	$101K	Hold	4,028	–	–	0.06%	30
2017 Q4	$89K	Hold	4,028	–	–	0.06%	31
2017 Q3	$212K	Buy	4,028 +1,500	+59%	+$78.9K	0.14%	33
2017 Q2	$229K	Hold	2,528	–	–	0.15%	32
2017 Q1	$209K	Buy	2,528 +882	+54%	+$72.9K	0.12%	33
2016 Q4	$249K	Buy	1,646 +945	+135%	+$143K	0.15%	33
2016 Q3	$227K	Sell	701 -76	-10%	-$24.6K	0.14%	34
2016 Q2	$253K	Sell	777 -70	-8%	-$22.8K	0.17%	34
2016 Q1	$284K	Buy	847 +201	+31%	+$67.4K	0.17%	33
2015 Q4	$251K	Buy	646 +49	+8%	+$19K	0.15%	36
2015 Q3	$245K	Buy	+597	New	+$245K	0.15%	39